Gastritis and constipation
Pro Research Analysisby 
Searched over 200M research papers
Gastritis and Constipation: Understanding the Connection
Prevalence and Impact of Constipation
Chronic constipation is a prevalent gastrointestinal disorder affecting approximately 15% of the global population, with higher rates observed in the elderly and women 123. Symptoms include straining, hard stools, infrequent defecation, and a sense of incomplete evacuation 13. The condition can significantly impair quality of life and is a common reason for medical consultations 14.
Mechanisms and Types of Constipation
Constipation can be classified into primary and secondary types. Primary constipation includes normal transit, slow transit, and defecatory disorders, while secondary constipation can result from medications or anatomical changes 13. Key pathogenic mechanisms involve colonic sensorimotor disturbances and pelvic floor dysfunction 13.
Management Strategies for Constipation
Management typically begins with dietary fiber supplementation and the use of stimulant or osmotic laxatives 13. For patients unresponsive to these treatments, options include intestinal secretagogues, prokinetic agents, and peripherally acting μ-opiate antagonists for opioid-induced constipation 13. Biofeedback therapy is effective for defecatory disorders, and in severe cases, surgical interventions like colectomy may be necessary 13.
Role of Diet and Probiotics
Dietary interventions, such as increasing fiber intake, are foundational in managing constipation 13. Recent studies highlight the benefits of polyphenol-rich foods like mango, which not only improve stool frequency and consistency but also reduce intestinal inflammation . Probiotics, such as Lactobacillus reuteri and Pediococcus pentosaceus, have shown promise in enhancing gut motility and modulating gut microbiota, thereby alleviating constipation symptoms 678.
Constipation in the Context of Gastroparesis
Constipation is a notable symptom in patients with gastroparesis, a condition characterized by delayed gastric emptying . Approximately 34% of gastroparesis patients experience severe constipation, which correlates with increased severity of gastroparesis symptoms and delayed colonic transit . This suggests a complex interplay between upper and lower gastrointestinal motility disorders.
Conclusion
Constipation is a multifaceted condition with significant implications for patient well-being. Effective management requires a comprehensive approach, including dietary modifications, pharmacological treatments, and, in some cases, surgical interventions. The emerging role of probiotics and polyphenol-rich foods offers promising adjunctive therapies. Understanding the relationship between constipation and other gastrointestinal conditions like gastroparesis is crucial for optimizing patient care.
Sources and full results
Most relevant research papers on this topic
Mechanisms, Evaluation, and Management of Chronic Constipation
Chronic constipation can be managed with dietary fiber, stimulant and osmotic laxatives, and various intestinal secretagogues and prokinetic agents, depending on the cause and patient needs.
Epidemiological study of elderly constipation in Beijing.
Elderly constipation prevalence in Beijing is similar to Western countries, with factors such as region, age, and past history of related illnesses significantly affecting the condition.
Chronic constipation: a survey of the patient perspective
Chronic constipation patients report high symptom prevalence, healthcare-seeking behavior, and satisfaction with traditional therapies, but limited data on healthcare-seeking behavior and satisfaction.
Polyphenol‐rich Mango (Mangifera indica L.) Ameliorate Functional Constipation Symptoms in Humans beyond Equivalent Amount of Fiber
Mango consumption significantly improves symptoms and biomarkers of chronic constipation beyond an equivalent amount of fiber.
Pediococcus pentosaceus B49 from human colostrum ameliorates constipation in mice.
P. pentosaceus B49 from human colostrum effectively relieves constipation in mice by shortening defecation time, increasing gastrointestinal transit rate, and stool production, and altering gut microbiota.
Dietary synbiotic ameliorates constipation through the modulation of gut microbiota and its metabolic function.
SBT intake improves constipation by regulating gut microbiota, promoting short-chain fatty acids production, and suppressing inflammatory responses in rats.
Constipation in Patients with Symptoms of Gastroparesis: Analysis of Symptoms and Gastrointestinal Transit
Severe/very severe constipation and delayed colon transit occur in a third of patients with gastroparesis symptoms, and is associated with severity of gastroparesis symptoms, presence of IBS, and small bowel and colon transit delay, but not gastric emptying delay.
DOI